The mission of the Lipidomics Shared Resource (LSR) is to provide cost-effective advanced methodology, state-of-the-art instrumentation, and expertise in the synthesis and analysis of bioactive lipids to Hollings Can- cer Center (HCC) members. The scientific goal of the LSR is to provide resources for studying lipid metabolism and signaling in cancer, for identifying bioactive lipids and their role in tumor cell biology, and for discovering and evaluating drugs that target lipid metabolic processes. By providing deep exploratory as well as high throughput lipidomic options to analyze cancer cells and tissues, combined with educational workshops, the LSR fosters interactions among basic, clinical and population scientists at HCC. To remain at the leading edge of an evolving field, since the last review, the LSR expanded services by investing in new equipment (Thermo TSQ-50003, SCIEX Q-Trap triple quadrupole/ion trap, Advion TriVersa Nanomat) and transferring equipment from the Cell & Molecular Imaging Shared Resource to LSR, adding MALDI imaging services to LSR (Bruker Faltonics AutoFlex III linear MALDI, and AutoFLexIII MALDI TOF-TOF). During the current cycle, the LSR di- rectly supported 45 cancer-related publications, three team science projects, multiple internally funded team- based projects, three individual cancer grants, two translational studies, and one phase 1 clinical trial. Under the leadership of Besim Ogretmen, PhD, the LSR has grown to become a nationally- and internationally-recog- nized scientific resource with novel sophisticated methods for measurement and analysis of bioactive lipid mol- ecules relevant to cancer initiation and progression. Ogretmen is a national leader in lipid biology with a partic- ular focus on sphingolipids, including glycosphingolipids. The LSR has integrated MALDI imaging capability for direct tissue analysis of sphingolipid species in tissues, drug distribution in tumor xenograft tissue and organs (brain, kidney, liver), and structure confirmation of drug or metabolite of interest by collision-induced fragmenta- tion. Thus, by combining mass spectrometry and MALDI imaging, this resource not only quantifies sphin- golipids in tissues, but can also provide information about their cellular location and distribution in tissues. The LSR is well poised to advance and support important emerging scientific disciplines in cancer research to HCC members and the broader scientific community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA138313-12
Application #
9926241
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
12
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29407
Bai, Aiping; Bielawska, Alicja; Rahmaniyan, Mehrdad et al. (2018) Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites. Bioorg Med Chem 26:6067-6075
Graboyes, Evan M; Kompelli, Anvesh R; Neskey, David M et al. (2018) Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg :
Burris, Jessica L; Rivera-Rivera, Jessica N; Armeson, Kent et al. (2018) Causal attributions and their impact on psychosocial functioning in head and neck cancer patient-caregiver dyads: a preliminary, longitudinal study. Qual Life Res :
Bea, Vivian J; Cunningham, Joan E; Alberg, Anthony J et al. (2018) Alcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship. Front Oncol 8:392
Panneer Selvam, Shanmugam; Roth, Braden M; Nganga, Rose et al. (2018) Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3. J Biol Chem 293:9784-9800
Wrangle, John M; Velcheti, Vamsidhar; Patel, Manish R et al. (2018) ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol 19:694-704
Janakiraman, Harinarayanan; House, Reniqua P; Gangaraju, Vamsi K et al. (2018) The Long (lncRNA) and Short (miRNA) of It: TGF?-Mediated Control of RNA-Binding Proteins and Noncoding RNAs. Mol Cancer Res 16:567-579
Jin, Junfei; Lu, Zhongyang; Li, Yanchun et al. (2018) LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages. J Leukoc Biol 104:843-853
Joseph, Anne M; Rothman, Alexander J; Almirall, Daniel et al. (2018) Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration. Am J Respir Crit Care Med 197:172-182
Rojewski, Alana M; Tanner, Nichole T; Dai, Lin et al. (2018) Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest 154:110-118

Showing the most recent 10 out of 536 publications